A Pilot Study--Randomized, Prospective, Single Site Trial Evaluating Raltegravir vs. Atazanavir in Combination With Truvada for the Treatment of Antiretroviral naive HIV Infected Patients.

Trial Profile

A Pilot Study--Randomized, Prospective, Single Site Trial Evaluating Raltegravir vs. Atazanavir in Combination With Truvada for the Treatment of Antiretroviral naive HIV Infected Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jan 2015

At a glance

  • Drugs Atazanavir; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir; Ritonavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms RAN
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jan 2012 Planned end date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top